DANIEL ANSARI

affiliated with the university
More filtering options
  1. Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?

    Linus Aronsson, Roland Andersson, Swahn, F. & Daniel Ansari, 2017 Oct 3, In : Scandinavian Journal of Gastroenterology. 52, 10, p. 1049-1051 3 p.

    Research output: Contribution to journalReview article

  2. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.

    Bauden, M., Pamart, D., Daniel Ansari, Herzog, M., Eccleston, M., Micallef, J., Bodil Andersson & Roland Andersson, 2015, In : Clinical Epigenetics. 7, 106.

    Research output: Contribution to journalArticle

  3. Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

    Bauden, M., Kristl, T., Sasor, A., Bodil Andersson, György Marko-Varga, Roland Andersson & Daniel Ansari, 2017 Dec 2, In : BMC Cancer. 17, 1, 810.

    Research output: Contribution to journalArticle

  4. Paradoxical role of hmgb1 in pancreatic cancer: Tumor suppressor or tumor promoter?

    Cebrián, M. J. G., Bauden, M., Roland Andersson, Holdenrieder, S. & Daniel Ansari, 2016 Sep 1, In : Anticancer research. 36, 9, p. 4381-4390 10 p.

    Research output: Contribution to journalReview article

  5. Personalizing pancreatic cancer medicine: what are the challenges?

    Danielsson, K., Daniel Ansari & Roland Andersson, 2013, In : Personalized Medicine. 10, 1, p. 45-59

    Research output: Contribution to journalReview article

  6. Targeting dendritic cells in pancreatic ductal adenocarcinoma

    Deicher, A., Roland Andersson, Bobby Tingstedt, Gert Lindell, Bauden, M. & Daniel Ansari, 2018 Jun 18, In : Cancer Cell International. 18, 1, 85.

    Research output: Contribution to journalReview article

  7. Pancreatic Cancer: The Role of Pancreatic Stellate Cells in Tumor Progression.

    Dunér, S., Jacob Lopatko Lindman, Daniel Ansari, Gundewar, C. & Roland Andersson, 2010, In : Pancreatology. 10, 6, p. 673-681

    Research output: Contribution to journalArticle

  8. The role of SPARC expression in pancreatic cancer progression and patient survival.

    Gundewar, C., Sasor, A., Said Hilmersson, K., Roland Andersson & Daniel Ansari, 2015, In : Scandinavian Journal of Gastroenterology. 50, 9, p. 1170-1174

    Research output: Contribution to journalArticle

  9. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma

    Dingyuan Hu, Daniel Ansari, Krzysztof Pawlowski, Qimin Zhou, Sasor, A., Charlotte Welinder, Kristl, T., Bauden, M., Melinda Rezeli, Jiang, Y., György Marko-Varga & Roland Andersson, 2018, In : Oncotarget. 9, 11, p. 9789-9807 19 p.

    Research output: Contribution to journalArticle

  10. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma

    Dingyuan Hu, Daniel Ansari, Qimin Zhou, Sasor, A., Hilmersson, K. S., Bauden, M., Jiang, Y. & Roland Andersson, 2018 Nov 12, In : BMC Cancer. 18, 1, 1 p.

    Research output: Contribution to journalArticle

  11. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma

    Dingyuan Hu, Daniel Ansari, Qimin Zhou, Sasor, A., Said Hilmersson, K. & Roland Andersson, 2019 Feb 8, In : World Journal of Surgical Oncology. 17, 1, 29.

    Research output: Contribution to journalArticle

  12. The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer

    Dingyuan Hu, Daniel Ansari, Bauden, M., Qimin Zhou & Roland Andersson, 2019, In : Anticancer research. 39, 4, p. 1661-1666 6 p.

    Research output: Contribution to journalReview article

  13. Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer

    Dingyuan Hu, Daniel Ansari, Qimin Zhou, Sasor, A., Hilmersson, K. S. & Roland Andersson, 2019, In : Scandinavian Journal of Gastroenterology. 54, 2, p. 246-251 6 p.

    Research output: Contribution to journalArticle

  14. Immune checkpoint therapy for pancreatic cancer

    Johansson, H., Roland Andersson, Bauden, M., Hammes, S., Holdenrieder, S. & Daniel Ansari, 2016 Nov 21, In : World Journal of Gastroenterology. 22, 43, p. 9457-9476 20 p.

    Research output: Contribution to journalReview article

  15. Radioimmunotherapy-a potential novel tool for pancreatic cancer therapy?

    Sahlin, M., Bauden, M., Roland Andersson & Daniel Ansari, 2015, In : Tumor Biology. 36, 6, p. 4053-4062

    Research output: Contribution to journalReview article

  16. Fast-track programmes for hepatopancreatic resections: where do we stand?

    Lidewij Spelt, Daniel Ansari, Sturesson, C., Bobby Tingstedt & Roland Andersson, 2011, In : HPB. 13, 12, p. 833-838

    Research output: Contribution to journalArticle

  17. The prognostic role of cancer stem cell markers for long-term outcome after resection of colonic liver metastases

    Lidewij Spelt, Sasor, A., Daniel Ansari, Hilmersson, K. S. & Roland Andersson, 2018 Jan 1, In : Anticancer research. 38, 1, p. 313-320 8 p.

    Research output: Contribution to journalArticle

  18. Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer

    Lidewij Spelt, Daniel Ansari, Swanling, M., Holka, P. & Roland Andersson, 2018, In : Annals of Gastroenterology. 31, 1, p. 115-120 6 p.

    Research output: Contribution to journalArticle

  19. Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

    Sun, C., Daniel Ansari, Roland Andersson & Wu, D-Q., 2012, In : World Journal of Gastroenterology. 18, 35, p. 4944-4958

    Research output: Contribution to journalArticle

  20. Proteome-based biomarkers in pancreatic cancer.

    Sun, C., Ann Rosendahl, Daniel Ansari & Roland Andersson, 2011, In : World Journal of Gastroenterology. 17, 44, p. 4845-4852

    Research output: Contribution to journalArticle

  21. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma

    Syren, P., Roland Andersson, Bauden, M. & Daniel Ansari, 2017 Jul 3, In : Scandinavian Journal of Gastroenterology. 52, 6-7, p. 668-673

    Research output: Contribution to journalReview article

  22. SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer.

    Juan Vaz, Daniel Ansari, Sasor, A. & Roland Andersson, 2015, In : Pancreas. 44, 7, p. 1024-1035

    Research output: Contribution to journalArticle

  23. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue

    Qimin Zhou, Roland Andersson, Dingyuan Hu, Bauden, M., Kristl, T., Sasor, A., Krzysztof Pawłowski, Pla, I., Hilmersson, K. S., Zhou, M., Lu, F., György Marko-Varga & Daniel Ansari, 2019, In : EBioMedicine. 43, p. 282-294 13 p.

    Research output: Contribution to journalArticle

  24. Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis

    Q. Zhou, Roland Andersson, Dingyuan Hu, Bauden, M., Sasor, A., Bygott, T., Krzysztof PawŁowski, Pla, I., György Marko-Varga & Daniel Ansari, 2019 Jun 29, In : Translational Research. 212, p. 67-79 13 p.

    Research output: Contribution to journalArticle

  25. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling

    Qimin Zhou, Bauden, M., Roland Andersson, Dingyuan Hu, György Marko-Varga, Xu, J., Sasor, A., Dai, H., Krzysztof Pawłowski, Said Hilmersson, K., Chen, X. & Daniel Ansari, 2020 Feb 13, In : Journal of Translational Medicine. 18, p. 1-10 77.

    Research output: Contribution to journalArticle

Previous 1 2 Next